<DOC>
	<DOCNO>NCT02074150</DOCNO>
	<brief_summary>Botox act nerve ending , yet nerve ending inside muscle , typically inject . All nerve terminate fascia , ASIS device precisely deliver Botox create subdermal bloodless space , skin muscle . Thus enhance prolong Botox 's efficacy , time prevent 's unnecessary adverse reaction distant spread , especially since Botox reason travel rest body way .</brief_summary>
	<brief_title>ASIS Botox Upper Limb Spasticity</brief_title>
	<detailed_description>Aim 1 6 month demonstrate ASIS device 's consistent performance 60 adult subject Upper limb Spasticity . Gadolinium inject ASIS subdermally ( 30 ) conventional intramuscularly ( 30 ) 7 muscle group : Biceps Brachii , Flexor Carpi Radialis , Flexor Carpi Ulnaris , Flexor Digitorum Profundus , Flexor Digitorum Sublimis , Adductor Pollicis , Flexor Pollicis Longus . An MRI take promptly Gadolinium injection , start reference , subsequent MRI take 6 hr , 12 hr , 24 hr later compare Persistent % . Since n't way measure level Gadolinium within , ( e.g . Botox ) matter , least Prolongation Gadolinium may approximate great longer Persistent % MRI . However , approximation work variable minimize population Upper limb Spasticity , particular 7 muscle group . Case point , patient Upper limb Spasticity presumably hyperactivity 7 muscle group , expectantly shorten Gadolinium intramuscularly Persistent % , somewhat reduced Gadolinium subdermally Persistent % well due agitation , thus Persistent % value Upper limb Spasticity patient like normal patient , even 7 different muscle group . Therefore , Relative Prolongation Ability Score total Persistent % subdermally total Persistent % intramuscularly , specific valuable indicator help u modify Botox dosage duration inject `` unknown '' subdermal bloodless space Aim 2 . Aim 2 12 month , use Botox , instead Gadolinium , demonstrate advantage ASIS device subdermally intramuscularly , 60 adult subject Upper limb Spasticity , particular 7 muscle group : Biceps Brachii , Flexor Carpi Radialis , Flexor Carpi Ulnaris , Flexor Digitorum Profundus , Flexor Digitorum Sublimis , Adductor Pollicis , Flexor Pollicis Longus . Hypothetically speaking , subdermal bloodless space patient e.g. , Upper limb Spasticity somehow fail show prolongation half-life Gadolinium Aim 1 , still proceed primary interest therapeutic comparison Botox Aim 2 , term improvement Physician Global Assessment Scale Ashworth score ( force require move extremity around joint ) , 6,12,18,24 , 30 week , reduction adverse reaction .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Muscle Hypertonia</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Adults history stroke result unilateral , upperlimb focal spasticity Wrist flexor tone 2 finger flexor tone 2 measure Ashworth Scale Ability understand follow verbal direction At least 1 functional disability item ( hygiene , dress , pain , limb posture ) rating 2 Disability Assessment Scale ( DAS ) At least 1 functional task score Day 0 meet follow criterion : nail filing less 6 , hand clean less 6 , hold water bottle less 4 , brush teeth less 4 , hold fruit ( small , medium , large equal . Stroke within 6 month study enrollment visit Females pregnant , nursing , plan pregnancy study period use reliable mean contraception Previous current Botox therapy type study limb Any medical condition may put patient increase risk Botox exposure disorder might interfere neuromuscular function Presence fix contracture study limb Limited use wrist finger</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Subdermal bloodless space</keyword>
	<keyword>Subdermal injection</keyword>
	<keyword>injectable EMG needle</keyword>
	<keyword>electrical stimulation</keyword>
	<keyword>MRI Gadolinium</keyword>
	<keyword>Upper Limb Spasticity</keyword>
	<keyword>intramuscular injection</keyword>
</DOC>